Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.3%

5 terminated out of 80 trials

Success Rate

88.4%

+1.9% vs benchmark

Late-Stage Pipeline

20%

16 trials in Phase 3/4

Results Transparency

18%

7 of 38 completed with results

Key Signals

7 with results88% success

Data Visualizations

Phase Distribution

68Total
Not Applicable (28)
Early P 1 (1)
P 1 (8)
P 2 (15)
P 3 (13)
P 4 (3)

Trial Status

Completed38
Unknown21
Recruiting8
Not Yet Recruiting7
Terminated5
Active Not Recruiting1

Trial Success Rate

88.4%

Benchmark: 86.5%

Based on 38 completed trials

Clinical Trials (80)

Showing 20 of 20 trials
NCT07451808Not ApplicableNot Yet Recruiting

Male Pelvic Floor Muscle Rehabilitation Exercises

NCT07442396Not ApplicableRecruiting

The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation

NCT07434271Phase 2RecruitingPrimary

Study to Evaluate the Potential Effects of KH-001 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outcomes, and Safety in Men With Lifelong Premature Ejaculation (LPE)

NCT04207723Not ApplicableRecruitingPrimary

Transcutaneous Posterior Tibial Nerve Stimulation for Premature Ejaculation

NCT06425211Not ApplicableRecruiting

Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation.

NCT07300774Not ApplicableNot Yet RecruitingPrimary

Vagus Nerve Stimulation in Premature Ejaculation

NCT07236632Not ApplicableNot Yet RecruitingPrimary

Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized Study

NCT07067970Not ApplicableNot Yet RecruitingPrimary

Comparison of the Efficacy and Safety of Dapoxetine, Kegel Exercises, and Acupuncture in the Treatment of Premature Ejaculation: A Randomized, Double-Blind, Placebo-Controlled Trial

NCT07057011Not ApplicableNot Yet RecruitingPrimary

Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy

NCT07036497CompletedPrimary

THE IMPACT OF VITAMIN B12 TREATMENT ON EJACULATORY FUNCTIONS IN MEN: SYMPTOMATIC RELIEF AND IMPROVED OUTCOMES

NCT06570135Not ApplicableRecruitingPrimary

Brain Activity During Sexual Behavior in Patients With Primary Premature Ejaculation a Clinical Trial

NCT02109302Not ApplicableCompletedPrimary

Primary Premature Ejaculation Genetics

NCT06851598Phase 2Active Not RecruitingPrimary

Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle for Premature Ejaculation

NCT06605469Recruiting

Ejaculatory and Orgasmic Dysfunction Registry

NCT06777199Not ApplicableCompletedPrimary

A Comparative Study of Selective Dorsal Neurectomy, Pulsed Radiofrequency Neuromodulation, and Intragranular Hyaluronic Acid Injection for Premature Ejaculation

NCT06677814RecruitingPrimary

Development and Validation of an Anxiety Disorder Prediction Model for Premature Ejaculation Patients

NCT06570512Not ApplicableCompleted

Transcutaneous Electrical Nerve Stimulation for the Treatment of Premature Ejaculation

NCT06571318Not ApplicableNot Yet RecruitingPrimary

Clinical Study to Reduce Premature Ejaculation in Healthy Adult Men

NCT06425224Phase 3RecruitingPrimary

Effectiveness and Safety of TENS Therapy for Premature Ejaculation

NCT03204890Not ApplicableCompletedPrimary

TPTNS for Treating Patients With Premature Ejaculation

Scroll to load more

Research Network

Activity Timeline